X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (19) 19
index medicus (16) 16
female (15) 15
male (15) 15
rheumatology (15) 15
child (14) 14
treatment outcome (12) 12
adolescent (11) 11
rheumatoid-arthritis (10) 10
arthritis, juvenile - drug therapy (9) 9
abridged index medicus (8) 8
arthritis (8) 8
double-blind method (7) 7
methotrexate (7) 7
antirheumatic agents - therapeutic use (6) 6
child, preschool (6) 6
children (6) 6
preliminary definition (6) 6
methotrexate - therapeutic use (5) 5
patients (5) 5
antirheumatic agents - adverse effects (4) 4
clinical trials (4) 4
corticosteroids (4) 4
double-blind (4) 4
drug therapy (4) 4
internal medicine (4) 4
juvenile idiopathic arthritis (4) 4
prospective studies (4) 4
severity of illness index (4) 4
therapy (4) 4
core set (3) 3
dermatomyositis (3) 3
drug administration schedule (3) 3
drug therapy, combination (3) 3
efficacy (3) 3
etanercept (3) 3
improvement (3) 3
juvenile arthritis (3) 3
medicine, general & internal (3) 3
morphea (3) 3
multicenter (3) 3
outcome assessment (3) 3
polymyositis (3) 3
prednisone (3) 3
retrospective studies (3) 3
surveys and questionnaires (3) 3
time factors (3) 3
tumor necrosis factor-alpha - antagonists & inhibitors (3) 3
young adult (3) 3
abatacept (2) 2
adrenal cortex hormones - therapeutic use (2) 2
canakinumab (2) 2
childhood (2) 2
clinical-trials (2) 2
cohort studies (2) 2
conjoint analysis (2) 2
consensus (2) 2
criteria (2) 2
dermatologic agents - adverse effects (2) 2
dermatomyositis - drug therapy (2) 2
disease-activity (2) 2
follow-up studies (2) 2
idiopathic inflammatory myopathies (2) 2
immunoconjugates - adverse effects (2) 2
immunoconjugates - therapeutic use (2) 2
infusions, intravenous (2) 2
journal article (2) 2
juvenile dermatomyositis (2) 2
kaplan-meier estimate (2) 2
linear scleroderma (2) 2
localized scleroderma (2) 2
logistic models (2) 2
macrophage activation syndrome (2) 2
medicine & public health (2) 2
methotrexate - administration & dosage (2) 2
methotrexate - adverse effects (2) 2
myositis (2) 2
onset stills-disease (2) 2
open-label (2) 2
pharmaceutical industry (2) 2
placebo-controlled trial (2) 2
quality (2) 2
quality of life (2) 2
quality-of-life (2) 2
receptor antagonist anakinra (2) 2
reproducibility of results (2) 2
response criteria (2) 2
rheumatoid arthritis (2) 2
rheumatoid factor (2) 2
risk factors (2) 2
rituximab (2) 2
safety (2) 2
scleroderma (2) 2
scleroderma, localized - drug therapy (2) 2
skin (2) 2
skin diseases (2) 2
societies, medical (2) 2
systemic scleroderma (2) 2
tocilizumab (2) 2
treatment (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Lancet, ISSN 0140-6736, 2016, Volume 387, Issue 10019, pp. 671 - 678
Journal Article
Lancet, The, ISSN 0140-6736, 2008, Volume 372, Issue 9636, pp. 383 - 391
Journal Article
Lancet, The, ISSN 0140-6736, 2017, Volume 389, Issue 10072, pp. 909 - 916
Journal Article
Arthritis & Rheumatology, ISSN 2326-5191, 10/2015, Volume 67, Issue 10, pp. 2759 - 2770
Journal Article
Arthritis Research & Therapy, ISSN 1478-6354, 01/2017, Volume 19, Issue 1, p. 13
Journal Article
Clinical Reviews in Allergy & Immunology, ISSN 1080-0549, 4/2012, Volume 42, Issue 2, pp. 131 - 134
The tumor necrosis factor alpha (TNFα) inhibitors have been used with good clinical results in the treatment of juvenile idiopathic arthritis (JIA). Anti TNFα... 
Allergology | Immunology | Medicine & Public Health | Adverse events | Internal Medicine | Skin manifestations | TNFα inhibitors | Juvenile idiopathic arthritis | NEW-ONSET | YANG | PSORIASIFORM | NECROSIS-FACTOR-ALPHA | ANTAGONIST THERAPY | IMMUNOLOGY | INFLIXIMAB THERAPY | LESIONS | TNF alpha inhibitors | ALLERGY | PSORIATIC SKIN | YIN | Follow-Up Studies | Lichen Planus - prevention & control | Humans | Antibodies, Monoclonal - adverse effects | Psoriasis - etiology | Male | Adrenal Cortex Hormones - therapeutic use | Arthritis, Juvenile - drug therapy | Young Adult | Antibodies, Monoclonal, Humanized - administration & dosage | Etanercept | Infliximab | Immunotherapy | Adult | Female | Psoriasis - prevention & control | Skin - pathology | Antibodies, Monoclonal, Humanized - adverse effects | Lichen Planus - etiology | Receptors, Tumor Necrosis Factor - administration & dosage | Vasculitis, Leukocytoclastic, Cutaneous - etiology | Immunoglobulin G - administration & dosage | Immunoglobulin G - adverse effects | Antibodies, Monoclonal - administration & dosage | Arthritis, Juvenile - immunology | Adolescent | Adalimumab | Arthritis, Juvenile - pathology | Tumor Necrosis Factor-alpha - antagonists & inhibitors | Vasculitis, Leukocytoclastic, Cutaneous - prevention & control | Complications and side effects | Rheumatoid factor | Psoriasis | Tumor necrosis factor | Arthritis | Skin | Cutaneous manifestations of general diseases | Drugs | pustulosis | etanercept | infliximab | Inflammation | Lichen planus | Reviews | Vasculitis | Scalp | Rheumatoid arthritis | Monoclonal antibodies | Skin diseases | Tumor necrosis factor- alpha
Journal Article
Annals of the Rheumatic Diseases, ISSN 0003-4967, 06/2015, Volume 74, Issue 6, pp. 1110 - 1117
Journal Article
Rheumatology International, ISSN 0172-8172, 4/2018, Volume 38, Issue S1, pp. 251 - 258
The Juvenile Arthritis Multidimensional Assessment Report (JAMAR) is a new parent/patient reported outcome measure that enables a thorough assessment of the... 
Medicine & Public Health | JAMAR | Rheumatology | Health Related Quality of Life | Disease status | Functional ability | Juvenile idiopathic arthritis | RHEUMATOID-ARTHRITIS | PARENT | SCALES | DISABILITY MEASUREMENT TOOL | IDIOPATHIC ARTHRITIS | RHEUMATOLOGY | CHILDREN | Juvenile arthritis | Patients | Arthritis | Quantitative psychology | Validation Studies
Journal Article
Journal Article
Journal Article